ArticleIrish journal of medical science2009
Late-onset CMV disease following CMV prophylaxis.
Article in Irish journal of medical science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Early versus delayed initiation of cytomegalovirus prophylaxis after liver transplant.Pharmacotherapy · 2022Article
- Cytomegalovirus Infection in Ireland: Seroprevalence, HLA Class I Alleles, and Implications.Medicine · 2016Observational
- CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.Frontiers in immunology · 2016Review
- Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Review
- Evaluation of cytomegalovirus infection after six months of liver transplantation in children in shiraz, southern iran.International journal of organ transplantation medicine · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCytomegalovirus (CMV) is the most common opportunistic infection after solid-organ transplantation, increasing morbidity and mortality. Three months of oral valganciclovir have been shown to provide effective prophylaxis. Late-onset CMV disease, occurring after the discontinuation of prophylaxis, is now increasingly recognised.
aimsTo investigate the incidence and the time of detection of CMV infections in liver transplant recipients who received CMV prophylaxis.
methodsRetrospective review of 64 high- and moderate-risk patients with 1 year of follow-up.
resultsThe incidence of CMV infection was 12.5%, with 4.7% disease. All cases of symptomatic CMV disease were of late-onset.
conclusionsThe incidence of CMV infections in this study was low compared with literature reports; however, the late-onset disease is an emerging problem. Detection of late-onset disease may be delayed because of less frequent clinic follow-up visits. Increased regular laboratory monitoring may allow earlier detection at the asymptomatic infection stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.